Evommune, Inc. EVMN
5.94 USD -0.07 (-1.16%)
At closeNov 3, 2026, 4:00 PM EST
5.94 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
5.87 Day range 6.11
4.94 52-week range 33.20
- YTD
- -65.30%
- 1 year
- -70.64%
Financial health
Altman Z-Score
3.66 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -1.5×
FY 2023 5y median -8.9× FY 2025
P/S 8.1×
FY 2023 5y median 86.9× FY 2025
P/B 0.5×
FY 2023 5y median -4.2× FY 2025
P/FCF -1.4×
FY 2023 5y median -10.4× FY 2025
EV/EBITDA -0.8×
FY 2023 5y median -12.0× FY 2025
EV/Sales 4.8×
FY 2023 5y median 112× FY 2025
FCF Yield -73.0%
FY 2023 5y median -9.6% FY 2025
Profitability
Gross Margin 100.0%
FY 2023 5y median 81.6% FY 2025
Operating Margin -623.6%
FY 2023 5y median -757.0% FY 2025
Net Margin -529.8%
FY 2023 5y median -681.1% FY 2025
ROE -33.5%
FY 2023 5y median 43.8% FY 2025
ROIC -39.1%
FY 2023 5y median -49.7% FY 2025
ROA -30.6%
FY 2023 5y median -41.4% FY 2025
Growth (YoY)
Revenue 85.7%
FY 2023 FY 2025
Operating Income -15.8%
FY 2023 FY 2025
EPS (diluted) -394.3%
FY 2023 FY 2025
Free Cash Flow -31.6%
FY 2023 FY 2025
Financial Health
Current Ratio 8.6×
FY 2023 5y median 8.6× FY 2025
Quick Ratio 8.6×
FY 2023 5y median 8.6× FY 2025
Debt / Equity 0.0×
FY 2023 5y median -1.3× FY 2025
Net Debt / EBITDA 0.5×
FY 2023 5y median -2.7× FY 2025
Interest Coverage 0.0×
FY 2023 5y median -653× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31